Quoin Pharmaceuticals (QNRX) Cash from Operations (2021 - 2026)
Quoin Pharmaceuticals (QNRX) posted Cash from Operations of 4868923.0 for Q1 2026, up 3.3% sequentially from 5035025.0 in Q4 2025, and down 87.69% YoY from 39541245.63 in Q1 2025.
Quoin Pharmaceuticals (QNRX) Cash from Operations (2021 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Cash from Operations for 6 years, with the latest figure at 4868923.0 in Q1 2026.
- Quarterly Cash from Operations fell 87.69% year-over-year to 4868923.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15815738.0 (down 75.4% YoY) and the FY2025 annual result came in at 13540994.0, down 72.34% from the prior year.
- Cash from Operations advanced to 4868923.0 in Q1 2026 per QNRX's latest filing, from 5035025.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1321524.0 in Q3 2023 and troughed at 5035025.0 in Q4 2025.
- A 5-year average of 2506611.0 and a median of 2179295.0 in 2024 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations plunged 152.71% in 2022, then surged 42.38% in 2023.
- Over 5 years, Cash from Operations stood at 1942342.0 in 2022, then slumped by 65.97% to 3223645.0 in 2023, then surged by 30.62% to 2236519.0 in 2024, then sank by 125.13% to 5035025.0 in 2025, then gained by 3.3% to 4868923.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 4868923.0, 5035025.0, and 2205969.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Quoin Pharmaceuticals | 531,643.73 | 531,643.73 | - | -3.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.87 Mn |
| Mar 31, 2026 | -4.87 Mn |
| Dec 31, 2025 | -5.04 Mn |
| Dec 31, 2025 | -5.04 Mn |
| Sep 30, 2025 | -2.21 Mn |
| Sep 30, 2025 | -2.21 Mn |
| Jun 30, 2025 | -3.71 Mn |
| Jun 30, 2025 | -3.71 Mn |
| Mar 31, 2025 | -2.59 Mn |
| Mar 31, 2025 | -2.59 Mn |
| Dec 31, 2024 | -2.24 Mn |
| Dec 31, 2024 | -2.24 Mn |
| Sep 30, 2024 | -2.18 Mn |
| Sep 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -2.01 Mn |
| Jun 30, 2024 | -2.01 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Dec 31, 2023 | -3.22 Mn |
| Dec 31, 2023 | -3.22 Mn |